WHY PIL

Keeping high-precision treatment
in daily use

Six design principles that work for both the clinic and management

Not a “sell-and-forget” device: from add-on installation on existing machines to clinical operation, our design works for the people on the floor and for management.

01

Retrofit to installed machines

Not only for new facilities: our software can be added to machines already in operation. Roughly 16,000 photon and 250 particle therapy machines worldwide are candidates. Hospitals gain the function without new capital investment.

02

PIL supports the regulatory amendment

For the device manufacturer’s partial-change application, PIL prepares the product documentation and supports the submission, applying the approach established with a Japanese device manufacturer.

03

In-house X-ray imaging control

We have developed our own synchronizer that precisely controls two X-ray tubes and flat-panel detectors, minimizing modifications on the machine side and shortening integration and verification.

04

Less training, less stress for staff

Automatic template generation and self-optimizing machine-learning dictionaries standardize the preparation steps. The system takes over the worry of “can we track this patient?”

05

Remote maintenance and continuous user feedback

During the small-scale introduction phase, maintenance is handled remotely and through the manufacturer. Issues and requests are collected continuously and returned as software updates.

06

Device-independent, easy to replace

Across photon, proton and carbon-ion therapy. With a Japanese device manufacturer we fully replaced the existing positioning and CBCT with PIL products, so we support both replacement and integration.

← Back to Why PIL?

How does an expensive machine affect the bottom line?

Particle therapy facilities carry large construction costs, and revenue is determined by fixed reimbursement points. Management therefore focuses on utilization and turnover rather than on treatment outcomes.

Points per courseFixed
×
Treatments per yearThe only variable that can be moved
=
Annual revenueCosts (depreciation, maintenance, staff) are fixed

→ The key management metric becomes “treatments per room per year”

Annual new-patient numbers vary widely between radiotherapy facilities in Japan
JASTRO 2019 structure survey, 734 facilities

127≤99216100–199156200–29978300–39959400–49998500+ New patients per year per facility (number of facilities; mean 280.6 patients)
1

Patient turnover

Room occupancy time and the number of fractions cap the annual case volume. At QST, two rooms treated about 600 cases per year with an average room occupancy of 9–10 minutes (non-gated).

2

Waiting time

Cases requiring metal marker implantation go through implantation, a fixation waiting period and then treatment start, extending lead time and causing lost opportunities for both patients and hospitals.

3

Staff burden

Respiratory gating and positioning tend to depend on skilled operators, making staffing and training a bottleneck for utilization.

4

Introduction and maintenance cost

Large facility costs mean long payback periods. Additional functions are more readily evaluated as “added value for the installed machine” than as new capital investment.

Sources: Japanese medical fee schedule M001-4 / Mori S, et al. Phys Med 2018;52:18-26 / JASTRO National Structure Survey of Radiotherapy Facilities 2019 (Report 1)

A sustainable package, not a one-time device sale

Introduction is not the end. We present, as part of the contract, a cycle in which operation → user feedback → improvement and updates → patient referral keep reinforcing each other.

1

Introduction and start-up

Regulatory documentation and submission support, implementation, training

2

Operational support and maintenance

Remote maintenance plus first-line response via the OEM keeps maintenance costs down

3

Voice of the user

Issues and requests collected continuously

4

Improvement and software updates

Tracking algorithms, UI and workflow improved and returned as updates

5

Referrals and facility network

Results, papers and know-how shared between user facilities and the device manufacturer

Value keeps circulating

Consideration for financial planning

  • Staged introduction, module by module
  • License and maintenance billed separately
  • Payment designed around the hospital’s investment decision and the OEM’s sales plan
  • Update and maintenance revenue shared with the device manufacturer
Items clarified in the evaluation agreementTarget machine, installation site and network conditions / installation responsibility / handling of evaluation data / ownership and publication of results / governing law

Contact

Let's solve medical imaging,
together.

Joint research, product development support, careers — feel free to get in touch.

Contact us